| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Poziotinib |
➤ Sign Up |
Amide derivative for inhibiting the growth of cancer cells |
Hanmi Holdings Co., Ltd. (Seoul, KR) |
➤ Sign Up |
| Poziotinib |
➤ Sign Up |
Method for EGFR directed combination treatment of non-small cell lung cancer |
Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) |
➤ Sign Up |
| Poziotinib |
➤ Sign Up |
Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)pi- peridin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used therein |
Hanmi Science Co., Ltd (Hwaseong-si, KR) |
➤ Sign Up |
| Poziotinib |
➤ Sign Up |
Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)pi- peridin-1-yi)prop-2-en-1-one |
Hanmi Pharm. Co., Ltd. (Gyeonggi-do, KR) |
➤ Sign Up |
| Poziotinib |
➤ Sign Up |
Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant |
Hanmi Pharm. Co., Ltd. (Gyeonggi-do, KR) |
➤ Sign Up |
| Poziotinib |
➤ Sign Up |
Pharmaceutical composition comprising amide derivative inhibiting the growth of cancer cells and non-metallic salt lubricant |
Hanmi Pharm. Co., Ltd. (Gyeonggi-do, KR) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
